Skip to content

Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section

Administration of Propofol for Prophylaxis of Intrathecal Morphine Induced Pruritus in Caesarean Section

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06188546
Enrollment
200
Registered
2024-01-03
Start date
2024-01-01
Completion date
2025-03-01
Last updated
2024-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus Caused by Drug

Keywords

morphine induced pruritus

Brief summary

the goal of this randomized clinical trial is to find the optimum sub hypnotic dose of iv propofol that prevents the incidence of itching induced from intrathecal morphine used in spinal anesthesia in caesarean section operation. the main questions it aim to answer are the number of patients complained of pruritus in the first 24 hours post operative period and the severity of the pruritus. participants will be divided into 4 groups. 1st group receives 0 mg of propofol , 2nd receives 10 mg , 3rd receives 20 mg and the 4th receives 30 mg.

Interventions

DRUGPropofol

trying different dosages of propofol 10mg/ml IV to determine the prophylactic dose for morphine induced pruritis

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. The study is scheduled for women undergoing elective caesarean section under spinal anesthesia. 2. The subject is ≥ 20 years and ≤ 40 years. 3. No obvious abnormalities in preoperative ECG, blood routine, electrolytes, and other tests. 4. ASA class 1-2.

Exclusion criteria

* Patients who had a known allergy to propofol, morphine, or bupivacaine. * Those with preexisting pruritus caused by pregnancy, a coexisting skin disorder, or other pruritogenic systemic diseases. * Patients with a contraindication to spinal anaesthesia * Failed block * Need of extra sedation intra-operative * Positive history for asthma or COPD. * Patient refusal

Design outcomes

Primary

MeasureTime frame
number of participants complained of pruritus in the first 24hr post operative periodfirst 24 hours post operative period

Contacts

Primary ContactSohila K Hassan, MBBCH
khaledsohila@gmail.com201010328326

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026